Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baroezet
- Development stage
- Phase 4
- Lead developer
- Daewoong Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Baroezet is a fixed-dose combination tablet containing pitavastatin (1 mg) and ezetimibe (10 mg) developed by Daewoong Pharmaceutical and manufactured by Ilsung IS. It is indicated for the treatment of primary hypercholesterolemia and dyslipidemia. Pitavastatin is an HMG-CoA reductase inhibitor that suppresses cholesterol synthesis in the liver, while ezetimibe is a cholesterol absorption inhibitor that targets the Niemann-Pick C1-Like 1 (NPC1L1) transporter in the small intestine. Together, this dual mechanism of action effectively lowers LDL cholesterol levels with a reduced risk of statin-associated side effects. Baroezet is also being evaluated in Phase 4 clinical trials (such as the MINI-STAR trial) for patients with minimal subclinical atherosclerosis.
- Brand names
- BaroEzet
- Other names
- ezetimibe + pitavastatinpitavastatin + ezetimibe
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)LDLR (Low-density lipoprotein receptor)NPC1L1 (Niemann-pick C1-Like 1 transporter)
Beyond the preview
Go deeper on Baroezet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baroezet.